MRNA bounce incoming
Posted: Nov 30, 2024
- Made a successful prediction on $NVDA breaking its upward trend line
- Recommends short term play on Moderna ($MRNA) for one to two weeks
- Stock has been in a downtrend but price has double bottomed at $35
- Volume has been higher, indicating smart buyers are stepping in
- Put call ratio for next week is extremely bullish, with more calls than puts
- Recommends buying 12/6 45 calls
- Confident in this play, similar to NVDA prediction, but not financial advice
What do people on Reddit think?
🚨 Reddit sentiment: mixed - There are various perspectives: some see a good bounce opportunity and long-term potential, while others are skeptical and highlight recent poor performance and regulatory concerns. Summarized comments: - Some users see an opportunity for a bounce and are buying calls for MRNA, comparing it to NVDA's previous setup - There is some skepticism about financial advice given, with a reminder that it's not financial advice - The stock has performed poorly on the NASDAQ 100, with concerns about RFK affecting it, but strong cash reserves and market cap are noted - Some believe in MRNA's long-term potential in rare diseases and cancer, with current undervaluation compared to its past during COVID times - A few consider short-term speculative trades on MRNA for quick gains - The possibility of human-to-human transmission of H5N1 bird flu is seen as a catalyst for future growth - Some are participating in the bird flu vaccine trial view this as a strategic investment - General mixed reactions, with some bullish on the prospect of short-term profits or long-term potential Stock tickers discussed: $MRNA
Stay ahead of the market with AI stock alerts & AI summaries of the latest earnings, stock ideas for free with Fluid Bot. Sign up now!